论文信息 - Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO - 字舞流文

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

B. Clotet | J. van Lunzen | A. Lazzarin | M. Cavassini | J. Molina | K. Henry | C. F. de Oliveira | N. Givens | C. Brennan | V. Kulagin